These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12359208)

  • 1. The role of signal transduction in cancer treatment and drug resistance.
    Liem AA; Chamberlain MP; Wolf CR; Thompson AM
    Eur J Surg Oncol; 2002 Sep; 28(6):679-84. PubMed ID: 12359208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of multidrug resistance in cancer.
    Gillet JP; Gottesman MM
    Methods Mol Biol; 2010; 596():47-76. PubMed ID: 19949920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of epithelial-mesenchymal transition in cancer drug resistance.
    Shang Y; Cai X; Fan D
    Curr Cancer Drug Targets; 2013 Nov; 13(9):915-29. PubMed ID: 24168191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of nitric oxide in cancer.
    Bonavida B; Khineche S; Huerta-Yepez S; Garbán H
    Drug Resist Updat; 2006 Jun; 9(3):157-73. PubMed ID: 16822706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrins and extracellular matrix: a novel mechanism of multidrug resistance.
    Elliott T; Sethi T
    Expert Rev Anticancer Ther; 2002 Aug; 2(4):449-59. PubMed ID: 12647988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming multidrug resistance in cancer: clinical studies of p-glycoprotein inhibitors.
    Coley HM
    Methods Mol Biol; 2010; 596():341-58. PubMed ID: 19949931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function.
    Gao L; Wu ZX; Assaraf YG; Chen ZS; Wang L
    Drug Resist Updat; 2021 Jul; 57():100770. PubMed ID: 34175687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?
    Bedard PL; Freedman OC; Howell A; Clemons M
    Breast Cancer Res Treat; 2008 Apr; 108(3):307-17. PubMed ID: 18351454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance in cancer.
    Baguley BC
    Methods Mol Biol; 2010; 596():1-14. PubMed ID: 19949917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming resistance to molecularly targeted anticancer therapies: Rational drug combinations based on EGFR and MAPK inhibition for solid tumours and haematologic malignancies.
    Tortora G; Bianco R; Daniele G; Ciardiello F; McCubrey JA; Ricciardi MR; Ciuffreda L; Cognetti F; Tafuri A; Milella M
    Drug Resist Updat; 2007 Jun; 10(3):81-100. PubMed ID: 17482503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant Role of MUC1 in Development of Resistance to Currently Existing Anti-cancer Therapeutic Agents.
    Farahmand L; Merikhian P; Jalili N; Darvishi B; Majidzadeh-A K
    Curr Cancer Drug Targets; 2018; 18(8):737-748. PubMed ID: 28669345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrandrine and cancer - An overview on the molecular approach.
    N B; K R C
    Biomed Pharmacother; 2018 Jan; 97():624-632. PubMed ID: 29101806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New targets for cancer chemotherapy.
    Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA
    Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208
    [No Abstract]   [Full Text] [Related]  

  • 15. Signal transduction pathways and transcriptional mechanisms of ABCB1/Pgp-mediated multiple drug resistance in human cancer cells.
    Sui H; Fan ZZ; Li Q
    J Int Med Res; 2012; 40(2):426-35. PubMed ID: 22613403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance in lung cancer.
    Nishio K; Nakamura T; Koh Y; Suzuki T; Fukumoto H; Saijo N
    Curr Opin Oncol; 1999 Mar; 11(2):109-15. PubMed ID: 10188075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ion channels and transporters in the development of drug resistance in cancer cells.
    Hoffmann EK; Lambert IH
    Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130109. PubMed ID: 24493757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells.
    Fessler SP; Wotkowicz MT; Mahanta SK; Bamdad C
    Breast Cancer Res Treat; 2009 Nov; 118(1):113-24. PubMed ID: 19415485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms for tumour resistance to chemotherapy.
    Pan ST; Li ZL; He ZX; Qiu JX; Zhou SF
    Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):723-37. PubMed ID: 27097837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment.
    Majidinia M; Alizadeh E; Yousefi B; Akbarzadeh M; Zarghami N
    Drug Res (Stuttg); 2016 Nov; 66(11):571-579. PubMed ID: 27701712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.